submitted by marc88 127 days ago (via pointpleasantpark.capital)
As shares tumbled yesterday, we finish the trading 7 days by seeking at the Sarepta Therapeutics Inc. (SRPT) update on Duchenne muscular dystrophy study.
0 Comments
Pages: 1 |